Findings by leading researchers demonstrate the promise and relevance of Simoa in vast application areas BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing ...
New research published in Lab on a Chip demonstrates 100x sensitivity improvement on Simoa; marks significant advancement in sensitivity for industry leading detection platform Quanterix has pioneered ...
LEXINGTON, Mass., Oct. 11, 2012 /PRNewswire/ -- Quanterix Corporation announced today that the Journal of Virological Methods published a key study describing the application of its ultra-sensitive ...
The Simoa Disc is the first diagnostic developed using Sony DADC's optical disc manufacturing technology; will be used in Simoa technology to improve testing quality in life science research LEXINGTON ...
Quanterix Corporation (NASDAQ: QTRX), announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea ...
Shares of molecular diagnostic company – Myriad Genetics, Inc. MYGN inched up 1% to close at $35.13 on Friday, subsequent to the launch of its latest immunoassay service by the company’s wholly owned ...
The most important practice learned after introducing multiple early technologies into regulated markets has been that interesting technologies create a starting point; developing a complete solution ...
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it has successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results